{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:39:32Z","timestamp":1790779172887,"version":"4.1.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/iae.0b013e318207d1dc","type":"journal-article","created":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T13:21:19Z","timestamp":1299590479000},"page":"1268-1278","source":"Crossref","is-referenced-by-count":61,"title":["LONG-TERM EFFECTIVENESS OF INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO ANGIOID STREAKS IN PSEUDOXANTHOMA ELASTICUM"],"prefix":"10.1097","volume":"31","author":[{"given":"Robert P","family":"Finger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Charbel","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Schmitz-Valckenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank G","family":"Holz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik N","family":"Scholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210130","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0039-6257(03)00053-5","article-title":"Pseudoxanthoma elasticum: a clinical, histopathological, and molecular update.","volume":"48","author":"Hu","year":"2003","journal-title":"Surv Ophthalmol"},{"key":"R2-6-20210130","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.survophthal.2008.12.006","article-title":"Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches.","volume":"54","author":"Finger","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"R3-6-20210130","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/jmg.2004.030171","article-title":"Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations.","volume":"42","author":"Chassaing","year":"2005","journal-title":"J Med Genet"},{"key":"R4-6-20210130","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00006982-200310000-00029","article-title":"Comet lesion: an ocular sign of pseudoxanthoma elasticum.","volume":"23","author":"Gass","year":"2003","journal-title":"Retina"},{"key":"R5-6-20210130","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archopht.123.7.923","article-title":"Spectrum of pattern dystrophy in pseudoxanthoma elasticum.","volume":"123","author":"Agarwal","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R7-6-20210130","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.1167\/iovs.09-3541","article-title":"Multimodal imaging including spectral domain OCT and confocal near infrared reflectance for characterisation of outer retinal pathology in pseudoxanthoma elasticum.","volume":"50","author":"Charbel Issa","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R8-6-20210130","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.ophtha.2009.11.008","article-title":"Centrifugal fundus abnormalities in pseudoxanthoma elasticum.","volume":"117","author":"Charbel Issa","year":"2010","journal-title":"Ophthalmology"},{"key":"R9-6-20210130","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/ICU.0b013e328329d173","article-title":"Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.","volume":"20","author":"Ciulla","year":"2009","journal-title":"Curr Opin Ophthalmol"},{"key":"R10-6-20210130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/bjo.2007.129916","article-title":"Intravitreal bevacizumab for choroidal neovascularisation associated with pseudoxanthoma elasticum.","volume":"92","author":"Finger","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R11-6-20210130","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1755-3768.2007.00895.x","article-title":"Treatment of choroidal neovascularization using intravitreal bevacizumab.","volume":"85","author":"Pedersen","year":"2007","journal-title":"Acta Ophthalmol Scand"},{"key":"R12-6-20210130","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1600-0420.2006.00762.x","article-title":"Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks.","volume":"84","author":"Teixeira","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"key":"R14-6-20210130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/bjo.2009.159160","article-title":"Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials.","volume":"94","author":"Mitchell","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"R15-6-20210130","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1097\/IAE.0b013e3181aade47","article-title":"Fundus autofluorescence in pseudoxanthoma elasticum.","volume":"29","author":"Finger","year":"2009","journal-title":"Retina"},{"key":"R16-6-20210130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00417-001-0413-3","article-title":"Analysis of digital scanning laser ophthalmoscopy fundus autofluorescence images of geographic atrophy in advanced age-related macular degeneration.","volume":"240","author":"Schmitz-Valckenberg","year":"2002","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R17-6-20210130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2415-5-8","article-title":"Automated analysis of digital fundus autofluorescence images of geographic atrophy in advanced age-related macular degeneration using confocal scanning laser ophthalmoscopy (cSLO).","volume":"5","author":"Deckert","year":"2005","journal-title":"BMC Ophthalmol"},{"key":"R18-6-20210130","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1038\/eye.2009.158","article-title":"Intravitreal ranibizumab for choroidal neovascularisation secondary to angioid streaks.","volume":"23","author":"Kang","year":"2009","journal-title":"Eye"},{"key":"R19-6-20210130","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.3129\/i09-107","article-title":"Rapid progression of angioid streaks following intravitreal bevacizumab.","volume":"44","author":"Sen","year":"2009","journal-title":"Can J Ophthalmol"},{"key":"R20-6-20210130","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000161879","article-title":"Intravitreal bevacizumab (Avastin) for choroidal neovascularization in angioid streaks: a case series.","volume":"223","author":"Donati","year":"2009","journal-title":"Ophthalmologica"},{"key":"R21-6-20210130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3928\/15428877-20090101-11","article-title":"Thirty-two month follow-up of successful treatment of choroidal neovascularization from angioid streaks with intravitreal bevacizumab.","volume":"40","author":"Kovach","year":"2009","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R22-6-20210130","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1755-3768.2008.01240.x","article-title":"Intravitreal pegabtanib sodium in choroidal neovascularization secondary to angioid streaks.","volume":"87","author":"Molina Guilabert","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"R23-6-20210130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/112067210901900125","article-title":"Choroidal neovascularization in angioid streaks and pseudoxanthoma elasticum: 1 year follow-up.","volume":"19","author":"Schiano Lomoriello","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"R24-6-20210130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/bjo.2008.143461","article-title":"Intravitreal bevacizumab (Avastin) treatment of choroidal neovascularisation in patients with angioid streaks.","volume":"93","author":"Wiegand","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"R25-6-20210130","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00347-006-1456-y","article-title":"[Intraocular application of bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks.","volume":"104","author":"Lommatzsch","year":"2007","journal-title":"] Ophthalmologe"},{"key":"R27-6-20210130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/bjo.2008.145896","article-title":"Long-term control of choroidal neovascularisation secondary to angioid streaks treated with intravitreal bevacizumab (Avastin).","volume":"93","author":"Neri","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"R28-6-20210130","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0140-6736(07)61104-0","article-title":"Clinical update: new treatments for age-related macular degeneration.","volume":"370","author":"Wong","year":"2007","journal-title":"Lancet"},{"key":"R29-6-20210130","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/bjo.2006.108795","article-title":"Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin).","volume":"91","author":"Gibran","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R30-6-20210130","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00417-009-1054-1","article-title":"Changes in choriocapillaris fenestration of rat eyes after intravitreal bevacizumab injection.","volume":"247","author":"Shimomura","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R31-6-20210130","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00417-009-1136-0","article-title":"Different properties of VEGF-antagonists: bevacizumab but not ranibizumab accumulates in RPE cells.","volume":"247","author":"Klettner","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006982-201107000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:26:27Z","timestamp":1618277187000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201107000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e318207d1dc","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}